Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Voll Non-Degradable Shoulder Spacer FIH Study

NCT: NCT07745647 · NOT_YET_RECRUITING

NCT IDNCT07745647
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2028-09
SponsorVoll Medical Technologies Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

The Voll Non-Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a non-degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).

Frequently Asked Questions

What is Voll Non-Degradable Shoulder Spacer FIH Study?

Voll Non-Degradable Shoulder Spacer FIH Study is a clinical trial registered under NCT07745647. Current status: NOT_YET_RECRUITING.

What is the status of NCT07745647?

The current status of NCT07745647 (Voll Non-Degradable Shoulder Spacer FIH Study) is: NOT_YET_RECRUITING.

When did Voll Non-Degradable Shoulder Spacer FIH Study start?

Voll Non-Degradable Shoulder Spacer FIH Study started on 2026-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑